← Back to Search

Telehealth vs In-Person Palliative Care for Lung Cancer (REACH PC Trial)

N/A

Waitlist Available

Led By Jennifer Temel, MD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Eastern Cooperative Oncology Group (ECOG) Performance Status from 0 (asymptomatic) to 3 (symptomatic and in bed >50% of the day)

Age > or = 18 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

REACH PC Trial Summary

This trial is testing different ways to give palliative care to people with newly diagnosed lung cancer and their families.

Who is the study for?

This trial is for adults over 18 with advanced non-small cell lung cancer, treated without the aim of cure and informed about their condition within the last 12 weeks. They must be able to communicate in English or Spanish, live where the care team is licensed, and have a close contact involved. Excluded are those already in outpatient palliative care or hospice, or with cognitive/psychiatric conditions affecting consent.Check my eligibility

What is being tested?

The study compares two ways of delivering palliative care: through telehealth services versus traditional in-person visits. It aims to determine which method better supports patients recently diagnosed with lung cancer and their families.See study design

What are the potential side effects?

Since this trial involves methods of care delivery rather than medication, there aren't typical drug side effects. However, participants may experience differences in satisfaction, convenience, emotional well-being based on whether they receive telehealth or in-person palliative care.

REACH PC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can take care of myself but may spend more than half the day in bed due to my condition.

Select...

I am 18 years old or older.

REACH PC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Caregiver satisfaction as measured by the Satisfaction with Care Delivery Questionnaire

Length of stay in hospice as collected per medical record review

Patient communication about end-of-life (EOL) care preferences as measured by patient self-report of communication about their wishes if they were dying

+2 more

Other outcome measures

Anxiety

Caregiver prognostic understanding as measured by the Prognosis and Treatment Perception Questionnaire (PTPQ)

Caregiver quality of life (QOL) as measured by the Caregiver Oncology QOL Questionnaire

+7 more

REACH PC Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TelehealthExperimental Treatment1 Intervention

Patients will meet with the PC clinician in person within four weeks of enrollment Subsequent visits with the PC clinician will be conducted with the patients in their home or other location using video at least every four weeks Patients may be scheduled to meet with the PC clinician in the clinic if requested by the patient or a clinician

Group II: In Person PCActive Control1 Intervention

Patients will be scheduled for their first In-person PC visit within four weeks of enrollment and then at least every four weeks thereafter until the patient is no longer coming into the clinic PC visits will be scheduled on the same day as an oncology visit if possible

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Palliative Care Research Cooperative GroupNETWORK

8 Previous Clinical Trials

912 Total Patients Enrolled

Massachusetts General HospitalLead Sponsor

2,928 Previous Clinical Trials

13,197,105 Total Patients Enrolled

Patient-Centered Outcomes Research InstituteOTHER

549 Previous Clinical Trials

29,995,298 Total Patients Enrolled

Media Library

In-person PC Clinical Trial Eligibility Overview. Trial Name: NCT03375489 — N/A

Lung Cancer Research Study Groups: Telehealth, In Person PC

Lung Cancer Clinical Trial 2023: In-person PC Highlights & Side Effects. Trial Name: NCT03375489 — N/A

In-person PC 2023 Treatment Timeline for Medical Study. Trial Name: NCT03375489 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the geographical distribution of this medical experiment?

"This clinical trial has centres located in Madison, Wisconsin; Los Angeles, California and Chicago, Illinois. In addition to those three sites there are 21 other locations that are participating in the study."

Answered by AI

Are more participants being sought for this clinical trial?

"The clinical trial is presently open for recruitment, with the initial posting being noted as June 15th 2018. The most recent update was provided on March 24th 2022."

Answered by AI

What is the overall capacity of this research endeavor?

"Affirmative. Clinicaltrials.gov showcases that this trial, which was posted on June 15th 2018, is currently in the process of accruing participants. 1250 individuals across 21 sites must be recruited to make up the study's sample size."

Answered by AI

Recent research and studies

Journal of Palliative MedicineJournal

Petrillo, Laura A., Areej El-Jawahri, Lauren B. Heuer, Kathryn Post, Emily R. Gallagher, Chardria Trotter, Madeleine Elyze, et al.. 2022. “Health-related Quality of Life and Depression Symptoms in a Cross Section of Patients with Advanced Lung Cancer Before and During the COVID-19 Pandemic”. Journal of Palliative Medicine. Mary Ann Liebert Inc. doi:10.1089/jpm.2022.0049.

clinicaltrials.govStudy

Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

Jennifer Temel, MD 2018. "Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03375489.

All > New Hampshire